Literature DB >> 12415556

Quinacrine-induced psychiatric disturbances in a child with common variable immunodeficiency and chronic giardiasis.

Ferah Genel1, Serpil Erermis, Guzide Aksu, Can Ozturk, Necil Kutukculer.   

Abstract

Psychiatric disorders due to quinacrine for antiparasitic therapy represent an infrequent, but serious, complication. The remarkable course of a 12-year-old boy with common variable immunodeficiency who developed severe psychiatric reactions following quinacrine therapy for his resistant chronic giardiasis is presented. The broad clinical spectrum of quinacrine-associated neuropsychiatric disturbances has been emphasized for the clinicians. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12415556     DOI: 10.1002/hup.427

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  4 in total

1.  Quinacrine induced mood disturbance--the unmasking of bipolar affective disorder.

Authors:  John Lally; Fintan Byrne; Elizabeth Walsh
Journal:  BMJ Case Rep       Date:  2012-06-21

2.  Results of lumbar puncture, CT and MRI in a case of quinacrine-induced psychosis involving a patient with cutaneous lupus erythematosus.

Authors:  Noura Matoug Al Osaimi; Carole Richford; John Thomas Kelsall
Journal:  Ther Adv Psychopharmacol       Date:  2016-12-25

3.  Randomized clinical study of five days apostrophe therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis in children.

Authors:  Roberto Canete; Angel A Escobedo; Maria E Gonzalez; Pedro Almirall
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

Review 4.  Treatment-refractory giardiasis: challenges and solutions.

Authors:  Marco Lalle; Kurt Hanevik
Journal:  Infect Drug Resist       Date:  2018-10-24       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.